Metraipolis › archive › dc_60f1e097bee5
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy — Europe PMC PMID:41330941
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41330941
- DOI
- 10.1038/s41523-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:46:35.702Z
- SHA-256 of the archived text
6d69e40875786f1b5e63c7b36070e94b176fd60e8a366c55c277c55ced27363b- Stable URL of this page
https://metraipolis.com/documento/dc_60f1e097bee5
How to cite
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy — Europe PMC PMID:41330941 — Europe PMC (en), https://europepmc.org/article/MED/41330941 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60f1e097bee5 (Metraipolis archive dc_60f1e097bee5, sha256 6d69e40875786f1b5e63c7b36070e94b176fd60e8a366c55c277c55ced27363b)
BibTeX
@misc{dc60f1e097bee5,
title = {HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy — Europe PMC PMID:41330941},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41330941},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60f1e097bee5; sha256 6d69e40875786f1b5e63c7b36070e94b176fd60e8a366c55c277c55ced27363b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41330941. Agents can read the archived copy with the MCP tool read_document.